CIK 0001840439
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | Faust Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +196,299 | 196,299 | ||
| 2025-06-11 | Faust Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +91,970 | 91,970 | ||
| 2024-06-12 | Faust Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +51,025 | 51,025 | ||
| 2023-06-14 | Faust Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +6,989 | 6,989 | ||
| 2022-06-22 | Faust Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +45,755 | 45,755 |
Page 1 of 1 · 5 trades